113 related articles for article (PubMed ID: 8003612)
21. Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease.
Betterle C; Zanette F; Zanchetta R; Pedini B; Trevisan A; Mantero F; Rigon F
Lancet; 1983 Jun; 1(8336):1238-41. PubMed ID: 6134038
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.
Myhre AG; Undlien DE; Løvås K; Uhlving S; Nedrebø BG; Fougner KJ; Trovik T; Sørheim JI; Husebye ES
J Clin Endocrinol Metab; 2002 Feb; 87(2):618-23. PubMed ID: 11836294
[TBL] [Abstract][Full Text] [Related]
23. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies.
Coco G; Dal Pra C; Presotto F; Albergoni MP; Canova C; Pedini B; Zanchetta R; Chen S; Furmaniak J; Rees Smith B; Mantero F; Betterle C
J Clin Endocrinol Metab; 2006 May; 91(5):1637-45. PubMed ID: 16522688
[TBL] [Abstract][Full Text] [Related]
24. Premature ovarian failure: autoimmunity and natural history.
Betterle C; Rossi A; Dalla Pria S; Artifoni A; Pedini B; Gavasso S; Caretto A
Clin Endocrinol (Oxf); 1993 Jul; 39(1):35-43. PubMed ID: 8348706
[TBL] [Abstract][Full Text] [Related]
25. Characterization of adrenal autoantigens recognized by sera from patients with autoimmune polyglandular syndrome (APS) type I.
Uibo R; Perheentupa J; Ovod V; Krohn KJ
J Autoimmun; 1994 Jun; 7(3):399-411. PubMed ID: 7916911
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
de Carmo Silva R; Kater CE; Dib SA; Laureti S; Forini F; Cosentino A; Falorni A
Eur J Endocrinol; 2000 Feb; 142(2):187-94. PubMed ID: 10664529
[TBL] [Abstract][Full Text] [Related]
27. Development of adrenocortical failure in non-Addisonian patients with antibodies to adrenal cortex. A clinical follow-up study.
Scherbaum WA; Berg PA
Clin Endocrinol (Oxf); 1982 Apr; 16(4):345-52. PubMed ID: 6896476
[TBL] [Abstract][Full Text] [Related]
28. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease.
Laureti S; De Bellis A; Muccitelli VI; Calcinaro F; Bizzarro A; Rossi R; Bellastella A; Santeusanio F; Falorni A
J Clin Endocrinol Metab; 1998 Oct; 83(10):3507-11. PubMed ID: 9768655
[TBL] [Abstract][Full Text] [Related]
29. Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease.
Laureti S; Arvat E; Candeloro P; Di Vito L; Ghigo E; Santeusanio F; Falorni A
Clin Endocrinol (Oxf); 2000 Jul; 53(1):107-15. PubMed ID: 10931087
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease.
Dal Pra C; Chen S; Furmaniak J; Smith BR; Pedini B; Moscon A; Zanchetta R; Betterle C
Eur J Endocrinol; 2003 May; 148(5):565-70. PubMed ID: 12720541
[TBL] [Abstract][Full Text] [Related]
31. [The incidence of the pituitary autoantibodies in Addison disease].
Gut P; Kosowicz J; Ziemnicka K; Baczyk M; Sowiński J
Endokrynol Pol; 2008; 59(6):490-4. PubMed ID: 19347814
[TBL] [Abstract][Full Text] [Related]
32. High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.
Dawoodji A; Chen JL; Shepherd D; Dalin F; Tarlton A; Alimohammadi M; Penna-Martinez M; Meyer G; Mitchell AL; Gan EH; Bratland E; Bensing S; Husebye ES; Pearce SH; Badenhoop K; Kämpe O; Cerundolo V
J Immunol; 2014 Sep; 193(5):2118-26. PubMed ID: 25063864
[TBL] [Abstract][Full Text] [Related]
33. The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease.
Bratland E; Bredholt G; Mellgren G; Knappskog PM; Mozes E; Husebye ES
J Autoimmun; 2009 Aug; 33(1):58-67. PubMed ID: 19329278
[TBL] [Abstract][Full Text] [Related]
34. Auto-immune Addison's disease in identical twins.
Simmonds JP; Lister J
Postgrad Med J; 1978 Aug; 54(634):552-4. PubMed ID: 569846
[TBL] [Abstract][Full Text] [Related]
35. Immunoprecipitation of human adrenal microsomal antigen.
Furmaniak J; Talbot D; Reinwein D; Benker G; Creagh FM; Rees Smith B
FEBS Lett; 1988 Apr; 231(1):25-8. PubMed ID: 3360129
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1.
Bøe AS; Bredholt G; Knappskog PM; Hjelmervik TO; Mellgren G; Winqvist O; Kämpe O; Husebye ES
Eur J Endocrinol; 2004 Jan; 150(1):49-56. PubMed ID: 14713279
[TBL] [Abstract][Full Text] [Related]
37. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4.
Betterle C; Dalpra C; Greggio N; Volpato M; Zanchetta R
Ann Endocrinol (Paris); 2001 Apr; 62(2):193-201. PubMed ID: 11353894
[TBL] [Abstract][Full Text] [Related]
38. A conformation-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxyl-terminal functional domain of human steroid 21-hydroxylase.
Nikoshkov A; Falorni A; Lajic S; Laureti S; Wedell A; Lernmark K; Luthman H
J Immunol; 1999 Feb; 162(4):2422-6. PubMed ID: 9973524
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune Addison's disease--evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency.
Furmaniak J; Kominami S; Asawa T; Wedlock N; Colls J; Smith BR
J Clin Endocrinol Metab; 1994 Nov; 79(5):1517-21. PubMed ID: 7962352
[TBL] [Abstract][Full Text] [Related]
40. Class II MHC expression in normal adrenal cortex and cortical cells in autoimmune Addison's disease.
Jackson R; McNicol AM; Farquharson M; Foulis AK
J Pathol; 1988 Jun; 155(2):113-20. PubMed ID: 3292733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
